Biotech News

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

Medpace (MEDP)Medpace2026-06-25 13:46 ESTEarnings

CINCINNATI --(BUSINESS WIRE)--Jan. 5, 2026-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026 . The Company will host a conference call the following

Open original release

Related news

Medpace

Medpace is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States